These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

744 related items for PubMed ID: 9091856

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of hemodialysis using cuprophan and polysulfone dialyzers on rosette tests, concentration of immunoglobulins and complement components in serum of patients with chronic renal failure].
    Starzyk J, Bartelik S, Sarnecka S.
    Wiad Lek; 1994 Jul; 47(13-14):523-6. PubMed ID: 7716940
    [Abstract] [Full Text] [Related]

  • 3. The influence of cuprophan and polysulfone membranes on dialyzer reusability and intradialytic complications.
    Kadiri S, Kehinde Z, Arije A, Salako BL.
    Afr J Med Med Sci; 2001 Sep; 30(3):191-4. PubMed ID: 14510127
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [C-reactive protein (CRP) as a marker of of hemodialysis biocompatibility].
    Szepietowski T, Krajewska M.
    Polim Med; 1997 Sep; 27(1-2):47-59. PubMed ID: 9380601
    [Abstract] [Full Text] [Related]

  • 6. [The effect of repeated use of cuprophane and polysulfone dialyzers during hemodialysis on the count of natural killer cells in blood].
    Liszka M, Moczulski D, Zukowska-Szczechowska E, Grzeszczak W, Religa Z.
    Pol Arch Med Wewn; 1997 Mar; 97(3):224-31. PubMed ID: 9333768
    [Abstract] [Full Text] [Related]

  • 7. [Does multiple use of a cuprophan dialyser influence levels of chromium and cadmium during hemodialysis in patients with chronic kidney failure?].
    Małecka J, Grzeszczak W, Zukowska-Szczechowska E, Jendryczko A, Baczyński R.
    Pol Arch Med Wewn; 1995 Dec; 94(6):482-7. PubMed ID: 8618810
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes.
    Mandolfo S, Tetta C, David S, Gervasio R, Ognibene D, Wratten ML, Tessore E, Imbasciati E.
    Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of re-utilization of cuprophan capillary dialysers with different liquids on their biocompatibility and effectiveness of elimination].
    Orłowski A, Szepietowski T.
    Polim Med; 1992 Nov; 22(1-2):59-72. PubMed ID: 1461837
    [Abstract] [Full Text] [Related]

  • 14. [Antioxidants and malondialdehyde during hemodialysis with cellulose diacetate and polysulfone membranes].
    Eiselt J, Racek J, Holecek V, Krejcová I, Opatrný K.
    Cas Lek Cesk; 1996 Nov 06; 135(21):691-4. PubMed ID: 8998818
    [Abstract] [Full Text] [Related]

  • 15. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA, Woffindin C, Cox PJ, Goldfinch M, Roberts SJ.
    Clin Nephrol; 1997 Oct 06; 48(4):253-9. PubMed ID: 9352161
    [Abstract] [Full Text] [Related]

  • 16. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
    Abdel-Naeem NM, Kandell NF, El-Shamaa AA, Harba TM, Abdel-Hady AA.
    J Egypt Soc Parasitol; 2005 Dec 06; 35(3 Suppl):1173-97. PubMed ID: 16363293
    [Abstract] [Full Text] [Related]

  • 17. Ofloxacin clearance during hemodialysis: a comparison of polysulfone and cellulose acetate hemodialyzers.
    Thalhammer F, Kletzmayr J, El Menyawi I, Kovarik J, Rosenkranz AR, Traunmüller F, Hörl WH, Burgmann H.
    Am J Kidney Dis; 1998 Oct 06; 32(4):642-5. PubMed ID: 9774127
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Granulocyte activation during hemodialysis.
    Hörl WH, Riegel W, Steinhauer HB, Wanner C, Thaiss F, Bozkurt F, Haag M, Schollmeyer P.
    Clin Nephrol; 1986 Oct 06; 26 Suppl 1():S30-4. PubMed ID: 3829465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.